C. Emmas

First name
Last name
Boggon, R., van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A., et al. (2011). Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction\textendasha hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. http://doi.org/10.1093/eurheartj/ehr340
Bakhai, A., Rigney, U., Hollis, S., & Emmas, C. (2012). Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.2308
Rapsomaniki, E., Thuresson, M., Yang, E., Blin, P., Hunt, P., Chung, S. C., et al. (2016). Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes. http://doi.org/10.1093/ehjqcco/qcw004
Wilding, J., Bailey, C., Rigney, U., Blak, B., Beekman, W., & Emmas, C. (2016). Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study. Diabetes Ther. http://doi.org/10.1007/s13300-016-0193-8
Wilding, J., Bailey, C., Rigney, U., Blak, B., Kok, M., & Emmas, C. (2017). Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. Prim Care Diabetes. http://doi.org/10.1016/j.pcd.2017.04.004